These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 16469113

  • 1. Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study.
    Hoppe B, Häupl T, Gruber R, Kiesewetter H, Burmester GR, Salama A, Dörner T.
    Arthritis Res Ther; 2006; 8(2):R34. PubMed ID: 16469113
    [Abstract] [Full Text] [Related]

  • 2. A functional haplotype of PADI4 gene in rheumatoid arthritis: positive correlation in a French population.
    Gandjbakhch F, Fajardy I, Ferré B, Dubucquoi S, Flipo RM, Roger N, Solau-Gervais E.
    J Rheumatol; 2009 May; 36(5):881-6. PubMed ID: 19332633
    [Abstract] [Full Text] [Related]

  • 3. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis.
    Cha S, Choi CB, Han TU, Kang CP, Kang C, Bae SC.
    Arthritis Rheum; 2007 May; 56(5):1454-63. PubMed ID: 17469103
    [Abstract] [Full Text] [Related]

  • 4. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis.
    Poór G, Nagy ZB, Schmidt Z, Brózik M, Merétey K, Gergely P.
    Ann N Y Acad Sci; 2007 Sep; 1110():23-32. PubMed ID: 17911417
    [Abstract] [Full Text] [Related]

  • 5. Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis.
    Hoppe B, Häupl T, Egerer K, Gruber R, Kiesewetter H, Salama A, Burmester GR, Dörner T.
    Ann Rheum Dis; 2009 Jun; 68(6):898-903. PubMed ID: 18633125
    [Abstract] [Full Text] [Related]

  • 6. Contribution of anti-CCP antibodies, proximal interphalangeal joint involvement, HLA-DRB1 shared epitope, and PADI4 as risk factors for the development of rheumatoid arthritis in palindromic rheumatism.
    Tamai M, Kawakami A, Iwamoto N, Arima K, Aoyagi K, Eguchi K.
    Scand J Rheumatol; 2010 Aug; 39(4):287-91. PubMed ID: 20476860
    [Abstract] [Full Text] [Related]

  • 7. A functional haplotype and expression of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Chinese.
    Fan LY, Wang WJ, Wang Q, Zong M, Yang L, Zhang H, Sun LS, Lu TB, Han J.
    Tissue Antigens; 2008 Nov; 72(5):469-73. PubMed ID: 18764812
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish population.
    Martinez A, Valdivia A, Pascual-Salcedo D, Lamas JR, Fernández-Arquero M, Balsa A, Fernández-Gutiérrez B, de la Concha EG, Urcelay E.
    Rheumatology (Oxford); 2005 Oct; 44(10):1263-6. PubMed ID: 15998632
    [Abstract] [Full Text] [Related]

  • 11. Association between PADI4 and rheumatoid arthritis: a replication study.
    Ikari K, Kuwahara M, Nakamura T, Momohara S, Hara M, Yamanaka H, Tomatsu T, Kamatani N.
    Arthritis Rheum; 2005 Oct; 52(10):3054-7. PubMed ID: 16200584
    [Abstract] [Full Text] [Related]

  • 12. Functional haplotypes of PADI4: relevance for rheumatoid arthritis specific synovial intracellular citrullinated proteins and anticitrullinated protein antibodies.
    Cantaert T, Coucke P, De Rycke L, Veys EM, De Keyser F, Baeten D.
    Ann Rheum Dis; 2005 Sep; 64(9):1316-20. PubMed ID: 15760928
    [Abstract] [Full Text] [Related]

  • 13. The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden.
    Kokkonen H, Johansson M, Innala L, Jidell E, Rantapää-Dahlqvist S.
    Arthritis Res Ther; 2007 Sep; 9(3):R56. PubMed ID: 17553139
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Genetic and genomic studies of PADI4 in rheumatoid arthritis.
    Harney SM, Meisel C, Sims AM, Woon PY, Wordsworth BP, Brown MA.
    Rheumatology (Oxford); 2005 Jul; 44(7):869-72. PubMed ID: 15814578
    [Abstract] [Full Text] [Related]

  • 19. Polymorphisms and functional haplotype in PADI4: further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican population.
    Guzmán-Guzmán IP, Reyes-Castillo Z, Muñoz-Barrios S, Ruiz-Noa Y, Martínez-Bonilla GE, Parra-Rojas I, Palafox-Sánchez CA, Muñoz-Valle JF.
    Immunol Lett; 2015 Feb; 163(2):214-20. PubMed ID: 25562673
    [Abstract] [Full Text] [Related]

  • 20. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.
    Huizinga TW, Amos CI, van der Helm-van Mil AH, Chen W, van Gaalen FA, Jawaheer D, Schreuder GM, Wener M, Breedveld FC, Ahmad N, Lum RF, de Vries RR, Gregersen PK, Toes RE, Criswell LA.
    Arthritis Rheum; 2005 Nov; 52(11):3433-8. PubMed ID: 16255021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.